Correlation Between Rani Therapeutics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Akero Therapeutics, you can compare the effects of market volatilities on Rani Therapeutics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Akero Therapeutics.
Diversification Opportunities for Rani Therapeutics and Akero Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rani and Akero is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Akero Therapeutics
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to under-perform the Akero Therapeutics. In addition to that, Rani Therapeutics is 1.31 times more volatile than Akero Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 5,166 in Akero Therapeutics on August 31, 2024 and sell it today you would lose (1,956) from holding Akero Therapeutics or give up 37.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rani Therapeutics Holdings vs. Akero Therapeutics
Performance |
| Timeline |
| Rani Therapeutics |
| Akero Therapeutics |
Rani Therapeutics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rani Therapeutics and Akero Therapeutics
The main advantage of trading using opposite Rani Therapeutics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance |